HemaSphere
(Aug 2023)
P1176: CLINICAL OUTCOMES OF NOVEL THERAPIES IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
- Jennifer Crombie,
- Monika Jun,
- Tongsheng Wang,
- Alex Mutebi,
- Anthony Wang,
- Anindit Chibber,
- Rajesh Kamalakar,
- Jon Ukropec,
- Julie Blaedel,
- Anupama Kalsekar
Affiliations
- Jennifer Crombie
- 1 Dana-Farber Cancer Institute, Boston, United States
- Monika Jun
- 2 Genmab US, Inc., Princeton, United States
- Tongsheng Wang
- 2 Genmab US, Inc., Princeton, United States
- Alex Mutebi
- 2 Genmab US, Inc., Princeton, United States
- Anthony Wang
- 3 AbbVie, Inc, North Chicago, United States
- Anindit Chibber
- 2 Genmab US, Inc., Princeton, United States
- Rajesh Kamalakar
- 3 AbbVie, Inc, North Chicago, United States
- Jon Ukropec
- 2 Genmab US, Inc., Princeton, United States
- Julie Blaedel
- 2 Genmab US, Inc., Princeton, United States
- Anupama Kalsekar
- 2 Genmab US, Inc., Princeton, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000971600.08888.70
- Journal volume & issue
-
Vol. 7
p.
e0888870
WeChat QR code